The need for broad spectrum and safe anti-epileptic drugs in childhood epilepsy

Acta Neurologica Belgica

Volumn 109, Issue 3, 2009, Pages 167-170

  Lagae, Lieven ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

AED; Broad spectrum; Childhood epilepsy; Lamotrigine; Levetiracetam; Side effects; Topiramate; Treatment; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; SULTIAME; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

BENIGN CHILDHOOD EPILEPSY; CHILD; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GENOTYPE; HUMAN; MEDICAL DECISION MAKING; PROGNOSIS; REVIEW; ROLANDIC EPILEPSY; SEIZURE; SMOKING CESSATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; CHILD; EPILEPSY; HUMANS;

EID: 70350515212     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Aldenkamp A, Vigevano F, Arzimanoglou A, Covanis A. Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurol Scand Suppl. 2006;184:1-13.
2. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 2004;3(10):618-621 (Pubitemid 39221928)
3. Biton V, Bourgeois BF; YTC/YTCE study investigators. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol. 2005;62(11):1705-1708
4. Ceulemans B. et al. Severe myoclonic epilepsy in infancy: toward an optimal treatment. J Child Neurol. 2004;19(7):516-521 (Pubitemid 39481251)
5. Cross JH. et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia. 2006;47(6):952-959
6. Di Corcia G, Blasetti A, De Simone M, Verrotti A, Chiarelli F. Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)". Eur J Paediatr Neurol. 2005;9(2):59-66.
7. Dinkelacker V, Dietl T, Widman G, Lengler U, Elger CE. Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases. Epilepsy Behav. 2003;4(5): 537-547 (Pubitemid 37407612)
8. Dunkley C, Cross JH. NICE guidelines and the epilepsies: how should practice change? Arch Dis Child. 2006;91(6):525-528
9. Elterman RD, Shields WD, MansfielD KA, Nakagawa J; US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology. 2001;57(8):1416-1421
10. French JA. et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62(8):1252-1260 (Pubitemid 38526035)
11. French JA. et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62(8):1261-1273 (Pubitemid 38526036)
12. Geelhoed M. et al. The accuracy of outcome prediction models for childhood-onset epilepsy. Epilepsia. 2005;46(9):1526-1532 (Pubitemid 43919492)
13. Glauser T. et al. ILAE treatment guidelines: evidence- based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7): 1094-1120 (Pubitemid 44086745)
14. Glauser TA, Clark PO, McGee K. Long-term response to topiramate in patients with West syndrome. Epilepsia. 2000;41 Suppl 1:S91-4.
15. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. 1998;39(12):1324-1328 (Pubitemid 29005632)
16. Glauser TA, Levisohn PM, Ritter F, Sachdeo RC. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia. 2000;41 Suppl 1:S86-90.
17. Guerrini R. et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39(5): 508-512 (Pubitemid 28221807)
18. Lagae L. et al. Anti-epileptogenesis research: the clinical relevance. Acta Neurol Belg. 2003;103(2):78-82.
19. Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure. 2005;14(1):66-71. (Pubitemid 40103960)
20. Lagae L. Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy. Seizure. 2006;15(4):235-241
21. Liu L. et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006;319(2):790-798 (Pubitemid 44776384)
22. Lüders H. et al. Semiological seizure classification. Epilepsia. 1998;39(9):1006-1013
23. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67(2):340-342 (Pubitemid 44313586)
24. Opp J. et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure. 2005;14(7):476-484
25. Peters JM, Camfield CS, Camfield PR. Population study of benign rolandic epilepsy: is treatment needed? Neurology. 2001;57(3):537-539
26. Rating D. Treatment in typical and atypical rolandic epilepsy. Epileptic Disord. 2000;2 Suppl 1:S69-72.
27. Sachdeo RC. et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 1999; 52(9):1882-1887
28. Silberstein SD, Ben-Menachem E, Shank RP, Wiegand F. Topiramate monotherapy in epilepsy and migraine prevention. Clin Ther. 2005;27(2):154-165 (Pubitemid 40462008)
29. Specchio LM. et al. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res. 2006;71(1): 32-39 (Pubitemid 44233197)
30. Vanderlinden L, Lagae LG. Clinical predictors for outcome in infants with epilepsy. Pediatr Neurol. 2004;31(1):52-55 (Pubitemid 38902851)